Oramed Appoints As Chief Strategy Officer Post author:Sam Post published:March 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Massachusetts' Inotek Exploring Strategic Alternatives After Another Glaucoma Trial Failure July 9, 2017 Endo International Slashes 875 Jobs and Will Shutter Alabama Facilities July 20, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Massachusetts' Inotek Exploring Strategic Alternatives After Another Glaucoma Trial Failure July 9, 2017